GESTATIONAL AND PERINATAL OUTCOMES AFTER TREATMENT OF  BACTERIAL VAGINOSIS DURING PREGNANCY

DAVID KOBESHAVIDZE; ZAZA BOKHUA; KONSTANTINE KHARABADZE

doi:10.52340/jecm.2023.05.12

GESTATIONAL AND PERINATAL OUTCOMES AFTER TREATMENT OF BACTERIAL VAGINOSIS DURING PREGNANCY

Authors

DAVID KOBESHAVIDZE
ZAZA BOKHUA
KONSTANTINE KHARABADZE

DOI:

https://doi.org/10.52340/jecm.2023.05.12

Keywords:

Bacterial vaginosis (BV), Selective screening, Fluomyzin, Gynoflor– Э

Abstract

Selective screening of bacterial vaginosis (BV) was performed during the I prenatal visit. On basis of detected cases 2 groups were formed. Women from I group (34) were treated with antiseptic and probiotic. Control group was equal – 28 women. Comparative analysis revealed marked tendency of decreasing specific gestational and different perinatal complications in the I group.

Downloads

Download data is not yet available.

References

Crane J.M.G., Mogee L.A. et al. Maternal and perinatal outcomes of pregnancies delivered at 23 weeks’ gestation. J. Obstet. Gynecol Can. 2015; 37: 214-24.

Donders G.G., Van Calsteren K. et al. Predictive value for preterm birth of abnormal vaginal flora, bacterial vaginosis and aerobic vaginitis during the first trimester of pregnancy. BJOG. 2009; 116(10): 1315-24.

Fauner A., Binder H. Chemotherapie der Candida – infection in der Schwangerschaft. Aciziliche Praxis. 1974; 26: 3060.

Garcia – Munoz R.F., Galan Henriquez G. et al. Outcomes of very-low-birht-weight infants exposed to maternal clinical chorioamnionitis: a multicentric study. Neonatology. 2014; 106: 229-34.

Goldenberg R.J., Culhane J.F. et al. Epidemiology and causes of preterm birth. Lancet. 2008; 371(9606): 75-84.

Grischenko O.V., LakhnoI.V., et al. Clinical and prognostic aspects of bacterial vaginosis treatment in pregnant women. Women’s Health/Zdorov’ezhenshchiny. 2006; (4): 69-72.

Lamont R.F., Sobel J.D., et al. The vaginal microbiome: new information about genital tract flora using molecular based techniques. BJOG. 2011; 118(5): 533-49.

Mercer B.M. Preterm premature rupture of the membranes Obstet. Gynecol. 2003; 101: 178-93.

Ozkinay E., Terek M.C. et al. The effectiveness of live lactobacilli in combination with low dose estriol (Gynoflor) to restore the vaginal flora after treatment of vaginal infections. BJOG. 2005; 112(2): 234-40.

Saigal S., Doyle L.W. An overview of mortality and sequelae of preterm birth from infancy to adulthood. Lancet. 2008; 371: 261-9.

Sobei J. Bacterial vaginosis: treatment. Up To Date; 2014.

Soylu H., Jefferies, A. et al. Rupture of membranes before the age of viability and birth after the age of viability: comparison of outcomes in a matched cohort study. J. Perinatol. 2010; 30: 645-9.

Vitali B., Cruciani F., et al. Vaginal microbiome and metabolome highlight specific signatures of bacterial vaginosis. Eur. J. Clin. Microbiol. Infect. Dis. 2015; 34(12): 2367-2376.

Wewalka G., Koller W. et al. Untersuchungenzut Beurteilung von Verfahren fur die Vaginaldesinfektion. Zentralbl. BacteriolMikrobiol. Hyg. B. 1984; 179(6): 555-65.